Schedule 13G ownership disclosure
QUINCE THERAPEUTICS INC
Security class unavailable · CUSIP: 22053A107
Event date: 2021-09-30
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 2,976,489
- Percent of class
- 10.0000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001562230-21-000134
- Form type
- SC 13G
- Filer
- Capital International Investors
- CIK
- CIK 1562230
- Filed
- Oct 08, 2021
- Reporting period
- Sep 30, 2021
- Description
- Schedule 13G beneficial ownership